Litcius/Paper detail

Infectious Bronchitis Coronavirus: Genome Evolution in Vaccinated and Non-Vaccinated SPF Chickens

Alexandre Flageul, Chantal Allée, Céline Courtillon, Véronique Béven, Hélène Quenault, Yannick Blanchard, Michel Amelot, D. Courtois, Sjaak de Wit, Nicolas Eterradossi, Béatrice Grasland, Paul A. Brown

2022Viruses15 citationsDOIOpen Access PDF

Abstract

Infectious Bronchitis virus (IBV) continues to cause significant economic losses for the chicken industry despite the use of many live IBV vaccines around the world. Several authors have suggested that vaccine-induced partial protection may contribute to the emergence of new IBV strains. In order to study this hypothesis, three passages of a challenge IBV were made in SPF chickens sham inoculated or vaccinated at day of age using a live vaccine heterologous to the challenge virus. All birds that were challenged with vaccine heterologous virus were positive for viral RNA. NGS analysis of viral RNA in the unvaccinated group showed a rapid selection of seven genetic variants, finally modifying the consensus genome of the viral population. Among them, five were non-synonymous, modifying one position in NSP 8, one in NSP 13, and three in the Spike protein. In the vaccinated group, one genetic variant was selected over the three passages. This synonymous modification was absent from the unvaccinated group. Under these conditions, the genome population of an IBV challenge virus evolved rapidly in both heterologous vaccinated and non-vaccinated birds, while the genetic changes that were selected and the locations of these were very different between the two groups.

Topics & Concepts

Infectious bronchitis virusVirologyBiologyHeterologousVirusGenomeAvian infectious bronchitisPopulationCoronavirusAttenuated vaccineAvian infectious bronchitis virusVaccinationGeneticsGeneCoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)VirulencePathologyDiseaseEnvironmental healthAnimal Virus Infections StudiesViral gastroenteritis research and epidemiologySARS-CoV-2 and COVID-19 Research